JCIE and the National Academy of Medicine brought together around 20 American and Japanese officials and experts in Washington DC for the 2023 US-Japan Global Health Dialogue. The discussion built on the global health outcomes of the May 2023 G7 Summit in Hiroshima, Japan, and offered an opportunity to examine potential areas of US-Japan collaboration on how to advance resilient, equitable, and sustainable universal health coverage (UHC); how to ensure timely and equitable access to medical countermeasures (MCMs) in times of crises; and how to ensure surge capacity to respond to future pandemics.
This meeting was held as part of JCIE’s US-Japan Global Health Dialogue, an initiative launched in 2017 to foster continued collaboration between the US and Japan on salient global health issues.
- Summary Report: English
Welcoming Remarks
KEIZO TAKEMI, Minister of Health, Labour and Welfare of Japan
Session 1: Advancing more resilient, equitable, and sustainable UHC through strengthening health systems
ATUL GAWANDE, Assistant for Global Health, US Agency for International Development (USAID)
KEIZO TAKEMI
Session 2: How to ensure timely and equitable access to MCMs and other medical tools to tackle health threats
DAWN O’CONNELL, Assistant Secretary for Preparedness and Response, U.S. Department
of Health and Human Services
OSAMU KUNII, CEO & Executive Director, Global Health Innovative Technology Fund
Session 3: How to ensure surge capacity to respond to future pandemics in terms of financing and workforce (surge financing and emergency workforce)
PAMELA HAMAMOTO, U.S. Chief Negotiator for the Pandemic Accord Negotiations,
Bureau of Global Health Security and Diplomacy, U.S. State Department
HIDEAKI IMAMURA, World Bank Group Executive Director representing Japan
Toast
TAMAKI TSUKADA, Deputy Chief of Mission, U.S. Embassy of Japan
Closing Remarks
VICTOR DZAU, U.S. National Academy of Medicine
CAYA LEWIS ATKINS, Chief Advisor for Policy and Strategy, Office of Global Affairs, US Department of Health and Human Services
SHYAM BISHEN, Head, Centre for Health and Healthcare, World Economic Forum
VICTOR DZAU, President, US National Academy of Medicine
SATOSHI EZOE, Director, Global Health Strategy Division, International Cooperation Bureau, Ministry of Foreign Affairs, Japan
ATUL GAWANDE, Assistant Administrator for Global Health, U.S. Agency for International Development
PAMELA HAMAMOTO, US Chief Negotiator for the Pandemic Accord Negotiations, Bureau of Global Health Security and Diplomacy, US State Department
RICHARD HATCHETT, Chief Executive Officer, Coalition for Epidemic Preparedness Innovations
EIJI HINOSHITA, Assistant Minister for Global Health and Welfare, Japanese Ministry of Health, Labour and Welfare
HIDEAKI IMAMURA, World Bank Group Executive Director representing Japan
OSAMU KUNII, Chief Executive Officer & Executive Director, Global Health Innovative Technology Fund
MAUREEN LICHTVELD, Dean, School of Public Health, University of Pittsburgh
JEANNE M. MARRAZZO, Director, Division of Infectious Diseases, University of Alabama at Birmingham; Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health (incoming)
DAWN O’CONNELL, Assistant Secretary for Preparedness and Response, US Department of Health and Human Services
ANDREA PALM, Deputy Secretary, US Department of Health and Human Services
CARLOS DEL RIO, Executive Associate Dean, Emory School of Medicine & Grady Health System; International Secretary, National Academy of Medicine
CECILIA MUNDACA SHAH, Director, Global Health, UN Foundation
KEIZO TAKEMI, Minister of Health, Labour and Welfare of Japan
TAMAKI TSUKADA, Deputy Chief of Mission, Embassy of Japan in the United States
MONIQUE VLEDDER, Practice Manager for the Global Health, Nutrition and Population, World Bank
HOWARD ZUCKER, Deputy Director for Global Health, US Centers for Disease Control and Prevention